A critical breakthrough in cancer investigation is occurring with the use of mini-antibodies to re-engage damaged p53. This essential malignant protector protein is frequently inactivated in many kinds of cancer, https://wildbookmarks.com/story22152212/nanobodies-reactivate-tumor-suppressor-p53-new-promising-pathway-for-cancer-treatment